Real-time enrollment status for this myasthenia gravis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:17 AM UTC
| NCT Number | NCT06106672 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis |
| Phase | Clinical Trial |
| Target Enrollment | 54 participants |
| Active Locations | 17 sites in the US |
| Sponsor | COUR Pharmaceutical Development Company, Inc. |
| Last Updated on CT.gov | February 13, 2025 (Feb 13, 2025) |
As of March 2, 2026: Clinical trial NCT06106672 is currently recruiting participants. This clinical trial study for myasthenia gravis is actively seeking new participants at 17 locations across the United States. The study is sponsored by COUR Pharmaceutical Development Company, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06106672 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06106672 was last updated Feb 13, 2025 (February 13, 2025). HelloStudys verifies this status automatically.